Searchable abstracts of presentations at key conferences in endocrinology

ea0063p378 | Thyroid 1 | ECE2019

Should the dose of levothyroxine be changed in hypothyroidism patients fasting during Ramadan?

Koca Arzu Or , Dağdeviren Murat , Altay Mustafa

Objective: Muslims worship by fasting from pre-dawn (suhoor) until sunset (iftar) for 30 days in the religious month of Ramadan. In addition to prolonged hunger, patients fasting with a diagnosis of hypothyroidism take their doses of levothyroxine outside of daytime fasting hours. This study compares thyroid functions of fasting hypothyroidism patients with the values before Ramadan.Methods: One hundred patients aged 18–65 years were included in the...

ea0063p952 | Diabetes, Obesity and Metabolism 3 | ECE2019

Autotaxin level in patients with type 2 diabetes mellitus or cardiovascular disease

Duran Iffet Dağdelen , Gulcelik Neşe Ersoz

Introduction: Autotaxin (ATX)[Ectonucleotide Pyrophosphatase /Phosphodiesterase family member 2 (ENPP2)] is a lysophospholipase D stimulating cell migration, metastasis and angiogenesis. ATX hydrolizes lysophosphatidylcholine (LPC) and produces bioactive lysophosphatidic acid(LPA). There are some clues about ATX–LPA pathway modulation may unlock the gate of metabolic derangement including diabetes formation or may impact formation of cardiovascular diseases via LPA’s...

ea0063ep12 | Adrenal and Neuroendocrine Tumours | ECE2019

Lost to follow-up in classic congenital adrenal hyperplasia: a case report

da Costa Cristiana Gomes , Matos Tania , do Vale Sonia

Introduction: Classic congenital adrenal hyperplasias (CAH) are mostly diagnosed in the first months/years of life and require a lifetime follow-up.Case report: A 33-year-old Caucasian man was admitted twice in the previous year to the emergency department; the first episode due to an acute tonsillitis, the second episode due to a lower respiratory tract infection, both associated with hyponatremia (125 mmol/l). Common causes of hyponatremia were exclude...

ea0036P61 | (1) | BSPED2014

Challenges of managing a 9-month old child with congenital hyperinsulinism within a secondary care setting

Chinoy Amish , Da Costa Alexandra Rodrigues , Ismail Dunia

Introduction: Congenital hyperinsulinism (CHI) typically presents in the neonate, however a minority of cases (~ 35%) present later in infancy and childhood. We report the challenging case of an older infant presenting with hypoglycaemia, diagnosed with CHI and managed entirely within a secondary care setting.Case report: A 9-month-old macrosomic (99th centile) infant presented to the Children’s Emergency Department with hypoglycaemia and a 1 week h...

ea0070ep35 | Adrenal and Cardiovascular Endocrinology | ECE2020

Mediastinal malgnant paraganglioma: An atypical presentation

Pinheiro Sara , Damasio Ines , Nunes da Silva Tiago , Leite Valeriano

Introduction: Mediastinal paragangliomas are rare. These tumours can be associated with increased morbidity and mortality when invasive growth to the heart, great vessels, esophagus and trachea occurs. Surgical resection, if feasible, is the treatment of choice.Case report: A 50-year-old man presented with severe and refractory left gluteal pain radiating to the posterior thigh for two months. The patient had no relevant medical history and no other symp...

ea0029p1778 | Thyroid cancer | ICEECE2012

Thyroid papillary carcinoma, 30 years of experience

Costa Leite B. , Neves S. , Moreira da Costa A. , Canha A.

Papillary carcinoma is the most common histological type of thyroid cancer. The optimal treatment remains controversial, particularly with regard to the papillary microcarcinoma (≤ 10 mm).The aim of this study is the characterization of patients with this condition undergoing surgery in our hospital over a period of 30 years, evaluating treatment outcomes.Between January 1, 1980 and December 31, 2010, a total of 564 patients ...

ea0022p507 | Growth factors | ECE2010

GH modulates migration of developing T cells

Dardenne Mireille , Smaniotto Salete , Da Cruz Daniela Mendes , Savino Wilson

In the context of the cross-talk between the neuroendocrine and immune systems, it is well known that GH exerts physiological effects in central as well as peripheral compartments of the immune system. GH modulates a variety of thymic functions. For example, GH upregulates proliferation of thymocytes and thymic epithelial cells. Accordingly, GH-transgenic mice, as well as animals and humans treated with exogenous GH, exhibit an enhanced cellularity in the organ. GH also stimul...

ea0015p187 | Endocrine tumours and neoplasia | SFEBES2008

Adenosine stimulates secretion of chromogranin A in enterochromaffin cells

Kalhan Atul , Lewis BM , Scanlon MF , Rees DA , Ham Jack

Neuroendocrine tumours of the GI tract originate from enterochromaffin cells. Somatostatin analogues are the mainstay drugs for therapy in these cancers as they ameliorate symptoms and lower hormone secretion, but only in 30–70% of patients. Such tumours are also associated with angiogenesis which has been used as a prognostic indicator; adenosine, the major regulator of angiogenesis, is released by enhanced degradation of ATP, during cellular stress, damage and hypoxia.<...

ea0011oc31 | Diabetes and metabolism | ECE2006

Comparative analysis of the effects of dehydroepiandrosterone (DHEA) on white and brown pre-adipocyte proliferation/differentiation

Rice SPL , Wang E , Scanlon MF , Ludgate M , Rees DA

Dehydroepiandrosterone (DHEA) is an adrenal sex steroid whose levels decline during normal aging. Epidemiological studies demonstrate inverse correlation between circulating DHEA-sulphate and body fat mass while DHEA administration in elderly subjects reduces visceral and subcutaneous fat accumulation. Although previous studies have shown that some effects may be mediated via DHEA-induced inhibition of white pre-adipocyte proliferation, mechanisms remain unknown. Furthermore, ...

ea0011p119 | Clinical case reports | ECE2006

Cushing’s syndrome in an adolescent with MEN1: where is the lesion?

Smeeton F , Davies JS , Scanlon MF , Rees DA

A 14 year old girl, with a family history of MEN1, presented with secondary amenorrhoea and weight gain. Biochemical investigation revealed raised 24-hour urinary free cortisol excretions (1455, 1190, 614 nmol/24 hours; normal <290) and failure of cortisol suppression following 48 hours of low dose (0.5 mg qds) dexamethasone (199 nmol/l to 202 nmol/l). High dose dexamethasone administration (2 mg qds) for 48 hours resulted in further suppression of serum cortisol to 49 nmo...